fgfr2b: a novel biomarker for patients with gastroesophageal cancer
Published 1 year ago • 67 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
2:17
claudin 18.2 and fgfr2b as novel targets in gastric cancer
-
1:07
claudin 18.2: a biomarker for gastric cancer
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
4:59
a novel biomarker for paediatic tumours
-
5:26
fight update: 1l bemarituzumab in fgfr2b gastric cancer
-
7:27
infigratinib for cca
-
13:47
asco gi: new data on fgfr inhibition with frontline bemarituzumab in gastroesophageal tumors
-
1:35
assessing the prevalence of cldn18.2 in gastric/gastroesophageal cancers
-
3:03
targeted therapies for gastroesophageal adenocarcinoma
-
4:51
natural history of patients with advanced cca with fgfr2 gene alterations or wild-type fgfr2
-
9:39
plasma kim-1 as a preoperative biomarker for rcc
-
2:37
developments in gastric and gastroesophageal cancer management
-
16:10
tcga: fgfr2 and fgfr3 mutations in lung squamous cell carcinoma - rachel liao
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
1:01
biomarkers evolve for treatment of lung cancers
-
14:47
fgfr as a tumour agnostic indicator and its importance in the diagnosis and treatment of multipl...
-
8:53
prognostic biomarkers to guide treatment of mcrpc
-
1:57
phase i results of a novel fgfr inhibitor